You Are On:
EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Volume
Most Active
Bulk Deals
Block Deals
Highest & Lowest Delivery
Analysis
Contribution to Index
Live Indices
Rising VDP
Rising VD & Falling Price
News Analysis
Hot Stocks
Opening Bell
Midday Review
Closing Bell
Other Market
Corporate News
Market Pulse
Economy
Company Result
FII Position
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratio
Share Price
MF Holdings
Price Charts
Company Chart
Company News
Cash Flow
Share Holding
Deliverable Volume
Historical Volume
Management Discussion
Corporate Action
BSE Announcements
Book Closure
Board Meetings
Bonus Issues
Right Issues
Split of Face Value
Dividend Details
Delisted Companies
Change Of Name
Other Market
FII Investments
DII Investments
World Indices
ADR Prices
Board of Directors
Glenmark Pharmaceuticals Ltd.
BSE Code
532296
ISIN Demat
INE935A01035
Book Value
650.55
NSE Code
GLENMARK
Dividend Yield(%)
0.23
Market Cap(Million)
304636.22
P/E(X)
73.21
EPS(Rs.)
14.75
Face Value(Rs.)
1
Chairman
Glenn Saldanha
Managing Director
Glenn Saldanha
Company Secretary
Harish Kuber
Executive Director
VS Mani
Promoter & Non-Executive Director
B E Saldanha
Non Executive Independent Director
Brian W Tempest
Rajesh V Desai
Sridhar Gorthi
DR Mehta
Saira Ramasastry
Vijayalakshmi Iyer
Dipankar Bhattacharjee
Whole Time Director
Cherylann Pinto